<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-1-101-106</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1176</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Клиническая эффективность персонифицированного расчета интраокулярной линзы у детей с врожденной катарактой при риске аномального рефрактогенеза</article-title><trans-title-group xml:lang="en"><trans-title>Clinical efficacy of individual intraocular lens calculation in children with congenital cataract at risk of abnormal refraction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0221-702X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хамраева</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Khamraeva</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лола Салимовна Хамраева — канд. мед. наук, доцент кафедры офтальмологии, детской офтальмологии</p><p>ул. Богишамол, д. 223, Ташкент, 100140</p></bio><bio xml:lang="en"><p>Lola S. Khamraeva — Cand. of Med. Sci., assistant professor of chair of ophthalmology, pediatric ophthalmology</p><p>223, Bogishamol St., Tashkent, 100140</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латипова</surname><given-names>Н. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Latipova</surname><given-names>N. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Надира Халимовна Латипова — канд. техн. наук, доцент кафедры системного и прикладного программирования</p><p>ул. Амир-Темура, д. 108, Ташкент, 100200</p></bio><bio xml:lang="en"><p>Nadira Kh. Latipova — Cand. of Tech. Sci., assistant professor of chair of system and applied programming</p><p>108, Amir Temur St., 100200, Tashkent</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6485-5751</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нарзуллаева</surname><given-names>Д. У.</given-names></name><name name-style="western" xml:lang="en"><surname>Narzullaeva</surname><given-names>D. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дилдора Уктамовна Нарзуллаева — соискатель базовойдокторантуры кафедры офтальмологии, детской офтальмологии</p><p>ул. Богишамол, д. 223, Ташкент, 100140</p></bio><bio xml:lang="en"><p>Dildora U. Narzullaeva — Applicant for basic doctoral studies at chair of ophthalmology, pediatric ophthalmology</p><p>223, Bogishamol St., Tashkent, 100140</p></bio><email xlink:type="simple">diladora@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентский педиатрический медицинский институт</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Tashkent Pediatric Medical Institute</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Университет информационных технологий</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>University of Information Technology</institution><country>Uzbekistan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>03</month><year>2023</year></pub-date><volume>16</volume><issue>1</issue><fpage>101</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хамраева Л.С., Латипова Н.Х., Нарзуллаева Д.У., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Хамраева Л.С., Латипова Н.Х., Нарзуллаева Д.У.</copyright-holder><copyright-holder xml:lang="en">Khamraeva L.S., Latipova N.K., Narzullaeva D.U.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1176">https://roj.igb.ru/jour/article/view/1176</self-uri><abstract><p>Цель работы — оценка клинической эффективности формулы SRK II с поправочным коэффициентом Rm для определения силы интраокулярной линзы (ИОЛ) у детей с врожденной катарактой (ВК) из группы риска псевдофакической миопии. Материал и методы. Комплексное обследование 48 детей (86 глаз) с ВК включало визометрию, тонометрию, тонографию, биомикроскопию, кератометрию, офтальмоскопию, ультразвуковое исследование, пахиметрию. Для определения силы ИОЛ использована формула SRK II с добавлением разработанного нами персонифицированного поправочного коэффициента Rm. Обследованные дети были разделены на две группы. В 1-ю, основную, включены 22 (42 глаза) ребенка, в данной группе расчет силы ИОЛ проводился с учетом Rm. Во 2-ю, контрольную, вошли 26 (44 глаза) детей, расчет силы ИОЛ в этой группе проводился по традиционной формуле SRK II с учетом возрастной гипокоррекции рефракции, но без коэффициента Rm. Результаты. Использование поправочного коэффициента Rm позволило достигнуть целевой рефракции у детей с риском развития псевдофакической близорукости (основная группа) в 83,3 % случаях (против 45,4 % случаев в группе контроля) и уменьшить развитие сильной относительно возраста рефракции на 37,9 %. У детей основной группы острота зрения повысилась до 0,500 ± 0,001, в группе контроля — до 0,200 ± 0,001. Заключение. Метод расчета оптической силы ИОЛ с применением персонифицированного поправочного коэффициента Rm по формуле SRK II − R − Rm может быть рекомендован для применения в клинической практике для детей из группы риска аномального рефрактогенеза.</p></abstract><trans-abstract xml:lang="en"><p>Purpose. To assess the clinical efficacy of the SRK II formula with a correction factor Rm in children with congenital cataracts who are at risk of pseudophakic myopia. Material and methods. A complex examination of 48 children (86 eyes) with congenital cataracts involved visometrics, tonometry, tonography, biomicroscopy, keratorefractometry, ophthalmoscopy, ultrasonography, and pachymetry. To determine the IOL power, we used the SRK II formula supplemented with the individual correction factor Rm, proposed by the authors. The examined children were divided into 2 groups. The main group 1 included 22 patients (42 eyes), for which the IOL power was calculated with the Rm factor. The control group 2 consisted of 26 patients (44 eyes) for which the IOL power was calculated according to the traditional SRK II formula using age-related hypocorrection of refraction but without the Rm coefficient. Results. The correction factor Rm, allowed us to achieve the targeted refraction in children who were at risk of developing pseudophakic myopia in 83.3 % of cases of the main group (versus 45.4 % of the control group cases) and reduce the development of high age-related refraction) by 37.9 %. In children of the main group, visual acuity reached, on average, 0.5 ± 0.001, while in the control group it was also higher but only reached 0.200 ± 0.001. Conclusion. The method of calculating the IOL optical power involving an individual correction factor Rm, according to the formula: SRK II – R – Rm can be recommended for clinical practice focused on children at risk of abnormal refractogenesis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>врожденная катаракта</kwd><kwd>хирургическое лечение</kwd><kwd>расчет силы интраокулярной линзы</kwd><kwd>аномальный рефрактогенез</kwd><kwd>псевдофакическая миопия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>congenital cataract</kwd><kwd>surgical treatment</kwd><kwd>calculation of intraocular lens power</kwd><kwd>abnormal refractogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Russell B., DuBois L., Lynn M., et al. for the Infant Aphakia Treatment Study Group. The Infant Aphakia Treatment Study Contact Lens Experience to Age 5 Years. Eye &amp;Contact Lens: Science &amp; Clinical Practice. 43 (6): 352–7, November 2017. doi: 10.1097/ICL.0000000000000291</mixed-citation><mixed-citation xml:lang="en">Russell B., DuBois L., Lynn M., et al. for the Infant Aphakia Treatment Study Group. The Infant Aphakia Treatment Study Contact Lens Experience to Age 5 Years. Eye &amp;Contact Lens: Science &amp; Clinical Practice. 43 (6): 352–7, November 2017. doi: 10.1097/ICL.0000000000000291</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nystrom A., Almarzouki N., Magnusson G., Zetterberg M. Phacoemulsification and primary implantation with bag-in-the-lens intraocular lens in children with unilateral and bilateral cataract. Acta Ophthalmol. 2018; 96: 364–70. doi: 10.1111/aos.13626</mixed-citation><mixed-citation xml:lang="en">Nystrom A., Almarzouki N., Magnusson G., Zetterberg M. Phacoemulsification and primary implantation with bag-in-the-lens intraocular lens in children with unilateral and bilateral cataract. Acta Ophthalmol. 2018; 96: 364–70. doi: 10.1111/aos.13626</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Хамраева Л.С., Нарзуллаева Д.У. Факторы, влияющие на целевую рефракцию у детей при артифакии после экстракции врожденной катаракты. Вестник офтальмологии. 2020; (3): 93–9. doi: 10.17116/oftalma202013603193</mixed-citation><mixed-citation xml:lang="en">Khamraeva L.S., Narzullaeva D.U. Factors affecting target refraction in children with pseudophakia after extraction of congenital cataract. Vestnik oftal’mologii. 2020; (3): 93–9 (in Russian). doi:10.17116/oftalma202013603193</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Аветисов С.Э. О коррекции аметропии после ранней хирургии врожденных катаракт. Вестник офтальмологии. 2003; 4: 24–8.</mixed-citation><mixed-citation xml:lang="en">Avetisov S.E. On the correction of ametropia after early surgery of congenital cataracts. Vestnik oftal’mologii. 2003; 4: 24–8 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Катаргина Л.А., Круглова Т.Б., Трифонова О.Б. и др. Рефракция при артифакии после хирургического лечения врожденных катаракт. Вестник офтальмологии. 2019; 135 (1): 36–41. doi: 10.17116/oftalma201913501136</mixed-citation><mixed-citation xml:lang="en">Katargina L.A., Kruglova T.B., Trifonova O.B., et al. Refraction in pseudophakia after surgical treatment of congenital cataracts. Vestnik oftal’mologii 2019; 135 (1): 36–41 (in Russian). doi: 10.17116/oftalma201913501136</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Trivedi R.H., Lambert S.R., Lynn M.J., Wilson M.E. Role of preoperative biometry in selecting initial contact lens power in IATS. JAAPOS. 2014; 18 (3): 251–254. doi: 10.1016/j.jaapos.2014.01.012</mixed-citation><mixed-citation xml:lang="en">Trivedi R.H., Lambert S.R., Lynn M.J., Wilson M.E. Role of preoperative biometry in selecting initial contact lens power in IATS. JAAPOS. 2014; 18 (3): 251–254. doi: 10.1016/j.jaapos.2014.01.012</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Круглова Т.Б., Кононов Л.Б. Особенности расчета оптической силы интраокулярной линзы, имплантируемой детям первого года жизни с врожденными катарактами. Вестник офтальмологии. 2013; 129 (4): 66–9. doi: 10.17116/oftalma201913501136</mixed-citation><mixed-citation xml:lang="en">Kruglova T.B., Kononov L.B. Peculiarities of intraocular lens power calculation in infants under 1 year of age with congenital cataracts. Vestnik oftal’mologii. 2013; 129 (4): 66–9 (in Russian). doi: 10.17116/oftalma201913501136</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Einighammer J., Oltrup T., Bendi T., Jean B. Calculating intraocular lens geometry by real ray tracing. J. Refract. Surg. 2007; 23 (4): 393–404.</mixed-citation><mixed-citation xml:lang="en">Einighammer J., Oltrup T., Bendi T., Jean B. Calculating intraocular lens geometry by real ray tracing. J. Refract. Surg. 2007; 23 (4): 393–404.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Weakley D., Cotsonis G., Wilson M.E., et al. Anisometropia at age 5 years after unilateral intraocular lens implantation during infancy in the infant aphakia treatment Study. Am. J. Ophthalmol. 2017; 180: 1–7. doi:10.1016/j.ajo.2017.05.008</mixed-citation><mixed-citation xml:lang="en">Weakley D., Cotsonis G., Wilson M.E., et al. Anisometropia at age 5 years after unilateral intraocular lens implantation during infancy in the infant aphakia treatment Study. Am. J. Ophthalmol. 2017; 180: 1–7. doi:10.1016/j.ajo.2017.05.008</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Хамраева Л.С., Нарзуллаева Д.У. Факторы риска и прогноза развития псевдофакической миопии у детей. Вестник офтальмологии. 2021; 2: 90–4. doi:10.17116/oftalma202113702190</mixed-citation><mixed-citation xml:lang="en">Khamraeva L.S., Narzullaeva D.U. Risk factors and prognosis for the development of pseudophakic myopia in children. Vestnik oftal’mologii. 2021; (2): 90–4 (in Russian). doi:10.17116/oftalma202113702190</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Solebo A.L., Cumberland P., Rahi J.S. British Isles Congenital Cataract Interest Group. 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IOL under 2 prospective inception cohort study. Lancet Child Adolesc. Health. 2018; 2: 863–71. doi: 10.1016/S2352-4642(18)30317-1</mixed-citation><mixed-citation xml:lang="en">Solebo A.L., Cumberland P., Rahi J.S. British Isles Congenital Cataract Interest Group. 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IOL under 2 prospective inception cohort study. Lancet Child Adolesc. Health. 2018; 2: 863–71. doi: 10.1016/S2352-4642(18)30317-1</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vasavada A.R., Vasavada V., Shah S.K., et al. Postoperative outcomes of intraocular lens implantation in the bag versus posterior optic capture in pediatric cataract surgery. J. Cataract Refract. Surg. 2017; 43: 1177–83. doi: 10.1016/j.jcrs.2017.07.022</mixed-citation><mixed-citation xml:lang="en">Vasavada A.R., Vasavada V., Shah S.K., et al. Postoperative outcomes of intraocular lens implantation in the bag versus posterior optic capture in pediatric cataract surgery. J. Cataract Refract. Surg. 2017; 43: 1177–83. doi: 10.1016/j.jcrs.2017.07.022</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Weakley D.R. Jr., Lynn M.J., Dubois L., et al.; Infant Aphakia Treatment Study Group. Myopic shift 5 years after intraocular lens implantation in the infant aphakia treatment study. Ophthalmology. 2017 Jun; 124 (6): 822–7. doi: 10.1016/j.ophtha. 2016.12.040</mixed-citation><mixed-citation xml:lang="en">Weakley D.R. Jr., Lynn M.J., Dubois L., et al.; Infant Aphakia Treatment Study Group. Myopic shift 5 years after intraocular lens implantation in the infant aphakia treatment study. Ophthalmology. 2017 Jun; 124 (6): 822–7. doi: 10.1016/j.ophtha. 2016.12.040</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gerson L.M., Marcia B.T., Fernando A.M. Refraction study on pseudophakic children. Ophthalmology. Brazil. 2005 Jun; 68 (3): 373–8. doi: 10.1590/s0004- 27492005000300018</mixed-citation><mixed-citation xml:lang="en">Gerson L.M., Marcia B.T., Fernando A.M. Refraction study on pseudophakic children. Ophthalmology. Brazil. 2005 Jun; 68 (3): 373–8. doi: 10.1590/s0004- 27492005000300018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Thouvenin, D., Lequeux L., Norbert O. IOL exchange for excessive myopic shift in 14 children operated for infantile cataract. Pediatric cataracts and pediatric glaucoma: 40 annual meeting EPOS. Barcelona; 2014: 48.</mixed-citation><mixed-citation xml:lang="en">Thouvenin, D., Lequeux L., Norbert O. IOL exchange for excessive myopic shift in 14 children operated for infantile cataract. Pediatric cataracts and pediatric glaucoma: 40 annual meeting EPOS. Barcelona; 2014: 48.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sachdeva V., Katukuri S., Kekunnaya R., et al. Validation of guidelines for undercorrection of intraocular lens power in children. Am. J. Ophthalmol. 2017; 174: 17–22. doi: 10.1016/j.ajo.2016.10.017</mixed-citation><mixed-citation xml:lang="en">Sachdeva V., Katukuri S., Kekunnaya R., et al. Validation of guidelines for undercorrection of intraocular lens power in children. Am. J. Ophthalmol. 2017; 174: 17–22. doi: 10.1016/j.ajo.2016.10.017</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sminia M. L., de Faber J.T.H.N., Doelwijt D.J., et al. Axial eye length growth and final refractive outcome after unilateral paediatric cataract surgery. Br. J. Ophthal 2010; 94: 547–50. doi: 10.1136/bjo.2009.160192</mixed-citation><mixed-citation xml:lang="en">Sminia M. L., de Faber J.T.H.N., Doelwijt D.J., et al. Axial eye length growth and final refractive outcome after unilateral paediatric cataract surgery. Br. J. Ophthal 2010; 94: 547–50. doi: 10.1136/bjo.2009.160192</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
